Atlas Trials

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

Clinical trial NCT05089227 · RECRUITING

Trial details

NCT number
NCT05089227
Sponsor
Centre Hospitalier Universitaire Dijon
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prolonged AnticoagulationVenous Thromboembolic DiseaseAutoimmune Hemolytic Anemia
Start date
2022-02-03
Primary completion
2028-08-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.